We are live on
!
Find out more
SPC
Slate Path Capital Portfolio holdings
AUM
$6.73B
1-Year Est. Return
95.97%
This Fund
S&P 500
This Quarter
Est. Return
+6.05%
1 Year Est. Return
+95.97%
3 Year Est. Return
+272.8%
5 Year Est. Return
+330.15%
10 Year Est. Return
+4,591.92%
AUM
$3.58B
AUM Growth
+$2.26B
(+171%)
Cap. Flow
+$2.1B
Cap. Flow
% of AUM
58.57%
Top 10 Holdings %
Top 10 Hldgs %
89.26%
Holding
21
New
8
Increased
1
Reduced
7
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$125M |
| 2 |
Allegion
ALLE
|
+$86.8M |
| 3 |
YOKU
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
|
+$49.5M |
| 4 |
Cleveland-Cliffs
CLF
|
+$14.5M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$11.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$91.4M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$73.9M |
| 3 |
Cheniere Energy
LNG
|
+$70.3M |
| 4 |
Marathon Petroleum
MPC
|
+$60.6M |
| 5 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$56.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 9.98% |
| 2 | Healthcare | 6.84% |
| 3 | Materials | 3.95% |
| 4 | Financials | 2.99% |
| 5 | Consumer Discretionary | 2.62% |
Similar funds
SPS
BHM
TAM
CIMLRA
FLPIM
JCAM
MSE
CF
Slate Path Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Slate Path Capital held 21 positions worth $3.58B, up 171% from $1.32B the previous quarter. Its ten largest holdings account for 89% of the portfolio.
Slate Path Capital deployed $2.1B of net new capital in Q2 2014, opening 8 new positions and adding to 1 existing holding. Its largest new stake was Intuitive Surgical: 2,826,000 shares worth $129M.
By sector, the portfolio is most concentrated in Communication Services at 10% of assets, down from 29% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was Trip.com Group, an estimated $91.4M trimmed.
- Slate Path Capital's largest Q2 2014 buy was Intuitive Surgical: 2,826,000 shares worth $129M.
- Slate Path Capital added most to Alnylam Pharmaceuticals in Q2 2014, an estimated $11.1M increase.
- Slate Path Capital's biggest Q2 2014 reduction was Trip.com Group, cutting an estimated $91.4M.
- Slate Path Capital fully exited Cheniere Energy in Q2 2014, selling an estimated $70.3M.
- Slate Path Capital's ten largest holdings make up 89% of its $3.58B portfolio in Q2 2014.
- Slate Path Capital opened 8 new positions and closed 3 in Q2 2014.
- Slate Path Capital's portfolio value rose 171% quarter-over-quarter to $3.58B.
Based on Slate Path Capital's 13F filing for Q2 2014, filed 14 Aug 2014.